These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 35463717)

  • 21. Rare deleterious variants of NOTCH1, GATA4, SMAD6, and ROBO4 are enriched in BAV with early onset complications but not in BAV with heritable thoracic aortic disease.
    Musfee FI; Guo D; Pinard AC; Hostetler EM; Blue EE; Nickerson DA; ; Bamshad MJ; Milewicz DM; Prakash SK
    Mol Genet Genomic Med; 2020 Oct; 8(10):e1406. PubMed ID: 32748548
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variants of Unknown Significance in Genes Associated with Heritable Thoracic Aortic Disease Can Be Low Penetrant "Risk Variants".
    Kwartler CS; Gong L; Chen J; Wang S; Kulmacz R; Duan XY; Janda A; Huang J; Kamm KE; Stull JT; Guo D; Milewicz DM
    Am J Hum Genet; 2018 Jul; 103(1):138-143. PubMed ID: 29961567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expert consensus recommendations on the cardiogenetic care for patients with thoracic aortic disease and their first-degree relatives.
    Verhagen JMA; Kempers M; Cozijnsen L; Bouma BJ; Duijnhouwer AL; Post JG; Hilhorst-Hofstee Y; Bekkers SCAM; Kerstjens-Frederikse WS; van Brakel TJ; Lambermon E; Wessels MW; Loeys BL; Roos-Hesselink JW; van de Laar IMBH;
    Int J Cardiol; 2018 May; 258():243-248. PubMed ID: 29452988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Implications of Identifying Pathogenic Variants in Individuals With Thoracic Aortic Dissection.
    Wolford BN; Hornsby WE; Guo D; Zhou W; Lin M; Farhat L; McNamara J; Driscoll A; Wu X; Schmidt EM; Norton EL; Mathis MR; Ganesh SK; Douville NJ; Brummett CM; Kitzman J; Chen YE; Kim K; Deeb GM; Patel H; Eagle KA; Milewicz DM; J Willer C; Yang B
    Circ Genom Precis Med; 2019 Jun; 12(6):e002476. PubMed ID: 31211624
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The natural history of type B aortic dissection in patients with PRKG1 mutation c.530G>A (p.Arg177Gln).
    Shalhub S; Regalado ES; Guo DC; Milewicz DM;
    J Vasc Surg; 2019 Sep; 70(3):718-723. PubMed ID: 30871887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative Risks of Initial Aortic Events Associated With Genetic Thoracic Aortic Disease.
    Regalado ES; Morris SA; Braverman AC; Hostetler EM; De Backer J; Li R; Pyeritz RE; Yetman AT; Cervi E; Shalhub S; Jeremy R; LeMaire S; Ouzounian M; Evangelista A; Boileau C; Jondeau G; Milewicz DM
    J Am Coll Cardiol; 2022 Aug; 80(9):857-869. PubMed ID: 36007983
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human
    Bhave SA; Guo DC; Angelov S; Bamshad MJ; Nickerson DA; Milewicz D; Wallingford MC
    Cardiogenetics; 2021 Sep; 11(3):132-138. PubMed ID: 36158166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic and Epigenetic Regulation of Aortic Aneurysms.
    Kim HW; Stansfield BK
    Biomed Res Int; 2017; 2017():7268521. PubMed ID: 28116311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks.
    Elefteriades JA
    Ann Thorac Surg; 2002 Nov; 74(5):S1877-80; discussion S1892-8. PubMed ID: 12440685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The genetics of aortopathies: Hereditary thoracic aortic aneurysms and dissections.
    Chou EL; Lindsay ME
    Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):136-148. PubMed ID: 32034893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial non-syndromal thoracic aortic aneurysms and dissections - Incidence and family screening outcomes.
    Robertson EN; van der Linde D; Sherrah AG; Vallely MP; Wilson M; Bannon PG; Jeremy RW
    Int J Cardiol; 2016 Oct; 220():43-51. PubMed ID: 27372041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing patterns for genetically triggered aortic and arterial aneurysms and dissections at an academic center.
    Hicks KL; Byers PH; Quiroga E; Pepin MG; Shalhub S
    J Vasc Surg; 2018 Sep; 68(3):701-711. PubMed ID: 29510914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel variants in the ACTA2 and MYH11 genes in a Cypriot family with thoracic aortic aneurysms: a case report.
    Keravnou A; Bashiardes E; Michailidou K; Soteriou M; Moushi A; Cariolou M
    BMC Med Genet; 2018 Dec; 19(1):208. PubMed ID: 30526509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Male-female differences in quality of life and coping style in patients with Marfan syndrome and hereditary thoracic aortic diseases.
    Thijssen CGE; Doze DE; Gökalp AL; Timmermans J; Peters JB; Elbers-van de Ven LHC; van Royen N; Takkenberg JJM; Roos-Hesselink JW; van Kimmenade RRJ
    J Genet Couns; 2020 Dec; 29(6):1259-1269. PubMed ID: 32519797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The genetic message of a sudden, unexpected death due to thoracic aortic dissection.
    Ripperger T; Tröger HD; Schmidtke J
    Forensic Sci Int; 2009 May; 187(1-3):1-5. PubMed ID: 19285815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endovascular repair of abdominal aortic aneurysm: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2002; 2(1):1-46. PubMed ID: 23074438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiomyopathy in Genetic Aortic Diseases.
    Muiño-Mosquera L; De Backer J
    Front Pediatr; 2021; 9():682390. PubMed ID: 34336739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there an immunogenomic difference between thoracic and abdominal aortic aneurysms?
    Yap ZJ; Sharif M; Bashir M
    J Card Surg; 2021 Apr; 36(4):1520-1530. PubMed ID: 33604952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thoracic aortic aneurysm: reading the enemy's playbook.
    Elefteriades JA
    Curr Probl Cardiol; 2008 May; 33(5):203-77. PubMed ID: 18439439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants.
    van de Laar IMBH; Arbustini E; Loeys B; Björck E; Murphy L; Groenink M; Kempers M; Timmermans J; Roos-Hesselink J; Benke K; Pepe G; Mulder B; Szabolcs Z; Teixidó-Turà G; Robert L; Emmanuel Y; Evangelista A; Pini A; von Kodolitsch Y; Jondeau G; De Backer J
    Orphanet J Rare Dis; 2019 Nov; 14(1):264. PubMed ID: 31752940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.